Pulmonary Embolism PE Therapeutics Pipeline Assessment and Market Forecasts to

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

MIV Therapeutics Inc - Strategic SWOT Analysis Review

MIV Therapeutics Inc - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

Summary MIV Therapeutics Inc. (MIVT) is a research and development company that develops biocompatible coatings for stents and other medical devices and advanced drug delivery systems. The company focuses in providing healing solutions for cardiovascular disease and other medical conditions. The company's ...

Industries: Therapy | Countries: Canada, United Kingdom

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • November 2014
  • 66 pages

Summary Chiesi Farmaceutici SpA (Chiesi) is a research focused pharmaceutical company. The company researches, develops and distributes pharmaceutical products with particular focus on respiratory, cardiovascular, and rare diseases. Its products include Atimos, Bramitob, Clenil, Curosurf, Foster, Iperten, ...

Industries: Therapy | Countries: World, Italy, Europe, United Kingdom, North America, United States, Czech Republic, France

EU5 Compression Therapy Market Outlook to 2020

EU5 Compression Therapy Market Outlook to 2020

  • $ 3 000
  • Industry report
  • by Global Data
  • October 2014
  • 273 pages

EU5 Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "EU5 Compression Therapy Market Outlook to 2020", provides key market data on the EU5 Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) ...

Industries: Therapy | Countries: France, Germany, Italy, United Kingdom, Spain, Europe

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market : Novel Inhaler Devices and Formulations are Impetuses for Growth

A Competitive Analysis of the Global Asthma and COPD Therapeutics Market : Novel Inhaler Devices and Formulations are Impetuses for Growth

  • $ 5 000
  • Industry report
  • by Frost & Sullivan
  • October 2014
  • 69 pages

Key Findings •Chronic obstructive pulmonary disorder (COPD) is the third leading cause of death in the United States, and is in fourth place in Europe and the rest of the world. •An estimated xxmillion people are affected by COPD globally. By 2020, COPD is projected to be the third leading cause ...

Industries: Therapy | Countries: World, United States, Europe, Australia, United Kingdom, Iceland, Denmark, Japan

United Kingdom Compression Therapy Market Outlook to 2020

United Kingdom Compression Therapy Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • October 2014
  • 67 pages

United Kingdom Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "United Kingdom Compression Therapy Market Outlook to 2020", provides key market data on the United Kingdom Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and ...

Industries: Therapy | Countries: United Kingdom

iCo Therapeutics Inc. (ICO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

iCo Therapeutics Inc. (ICO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 34 pages

Summary iCo Therapeutics Inc. (iCo) is a development stage pharmaceutical company that develops and commercializes drug candidates for treating ocular and systemic fungal diseases. The product pipeline of the company consists of three compounds, namely, iCo-007, iCo-008 and Oral AmpB Delivery System. ...

Industries: Therapy | Countries: Canada, United Kingdom

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 4 995
  • Industry report
  • by GBI Research
  • July 2014
  • 72 pages

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to ...

Industries: Therapy | Countries: France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 60 pages

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 - 40% and is region/climate dependent. For those patients failing to respond to symptomatic treatments ...

Industries: Therapy | Countries: Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 4 995
  • Industry report
  • by GBI Research
  • June 2014
  • 112 pages

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business intelligence provider, has released its latest research report, “Glioblastoma Multiforme Therapeutics ...

Industries: Therapy | Countries: World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 4 995
  • Industry report
  • by GBI Research
  • April 2014
  • 122 pages

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma Therapeutics ...

Industries: Therapy | Countries: World, Japan, Canada, Europe, United States, Spain, Italy, France, Germany, United Kingdom, North America

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.